CurveBeam AI (ASX:CVB) EBITDA Margin % : -335.14% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CurveBeam AI's EBITDA for the six months ended in Dec. 2023 was A$-11.46 Mil. CurveBeam AI's Revenue for the six months ended in Dec. 2023 was A$3.42 Mil. Therefore, CurveBeam AI's EBITDA margin for the quarter that ended in Dec. 2023 was -335.14%.

CurveBeam AI EBITDA Margin % Historical Data

The historical data trend for CurveBeam AI's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI EBITDA Margin % Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

EBITDA Margin %

-82.55

-121.81

-540.24

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
EBITDA Margin %	-	-117.54	-125.17	-	-335.14

Competitive Comparison of CurveBeam AI's EBITDA Margin %

For the Medical Devices subindustry, CurveBeam AI's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CurveBeam AI's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's EBITDA Margin % falls into.

CurveBeam AI EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CurveBeam AI's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-43.516	/	8.055
	=	-540.24 %

CurveBeam AI's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-11.455	/	3.418
	=	-335.14 %

CurveBeam AI (ASX:CVB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

CurveBeam AI EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines